Experimental study on the inhibitory effect of Carboxymethyl Pachymaram on hepatitis B virus expression from transfected cells.
- Author:
Hui-ping DHAN
1
;
An-ji HOU
;
Fu-er LU
;
Jiu-le HUANG
Author Information
- Publication Type:Journal Article
- MeSH: Antiviral Agents; pharmacology; Cell Line, Tumor; Cell Survival; drug effects; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glucans; pharmacology; Hepatitis B Surface Antigens; metabolism; Hepatitis B e Antigens; metabolism; Hepatitis B virus; drug effects; growth & development; immunology; Humans; Time Factors
- From: Chinese Journal of Experimental and Clinical Virology 2005;19(3):290-292
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the anti-HBV activity of Carboxymethyl Pachymaram (CMP) on the culturing of 2.2.15 cell line.
METHODSConcentrations of 20.0 g/L, 12.0 g/L, 6.0 g/L, 3.0 g/L, 1.5 g/L of CMP were used to evaluate its toxicity to the cell line and the inhibition rates of the secretion of HBsAg and HBeAg in the cultured 2.2.15 cell line.
RESULTSExperiments showed that the mean half toxicity concentration of CMP for 2.2.15 cell line was 13.6 g/L and concentration for 50% inhibition of the secretion of HBsAg and HBeAg were 4.45 g/L, 5.61 g/L and TI were 3.06 and 2.42. CMP showed stronger effect on anti-HBV than aciclovir.
CONCLUSIONCMP has good inhibitory effect on the secretion of HBsAg and HBeAg on cultured cell line 2.2.15.
